Clinical Trial

Personalized Shared Eye-care Identification of Age-related Macular Degeneration Using Artificial Intelligence and Telemedicine by Matching Optometrist Office-based Sites With Clinical Supervision

Study acronym: PYRENEES
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated June 21, 2024 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Office-based optometrist centres equipped with low-cost OCT devices can be used for screening of age-related macular degeneration. Matching next-door optometrist centres with clinical sites introduces a shared care service in an unprecedented and broad manner and offers timely and inclusive access to eye care for all citizens affected by the most frequent blinding disease in western countries. The aim of the study is to detect AMD in a next-door office-based setting on an individual level using low-cost OCT, through a telemedicine feedback loop. The specific aims of this study are: * Setting up a network of optometrist centres matched to clinical sites to perform shared care to protect eyesight in the elderly population. * Identify imaging biomarkers of age-related macular degeneration from OCT imaging. * Give a risk estimation of progression using a one-time low-cost OCT scan
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06465212
Lead Sponsor Medical University of Vienna
Conditions Age-Related Macular Degeneration
Enrollment 5,000 participants
Start Date 2024-07
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-06-21